Back to Rankings

IBRX

ImmunityBioA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
IBRX vs peer average
80/100
IBRX vs. peer average (A vs. C)
Grade spread
A 1 · B 3 · C 2 · D 4
Graded peers loaded
Coverage
10 graded
91% of tracked

Peer overview

AUPH is the first available peer comparator.

Closest size-matched commercial biopharma comparator in the packet; useful for judging whether IBRX can convert a single marketed specialty asset into durable revenue and narrower financing risk.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerAUPHAurinia
IBRX
ImmunityBio
AUPH
Aurinia
Grade
A
B
Momentum
91
48
Value
41
65
Sentiment
54
57
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs AUPH

IBRX / AUPH
Grade Position
Above peers
IBRX vs. peer average (A vs. C)
80/100
Momentum
91
IBRX
Value
41
AUPH
Sentiment
54
AUPH

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs IBRX
1
AUPH
AUPH
B
80/100
+1
2
REGN
REGN
C
60/100
+2
3
GLPG
GLPG
-
-
-
4
CORT
Corcept Therapeutics Inc. Common
B
80/100
+1
5
QGEN
QIAGEN NV Common
D
40/100
+3
AUPH is the first peer returned for this comparison set.